Who Supplies Everolimus? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Everolimus exports, with 87+ registered manufacturers shipping to buyers across 67+ countries — yet a handful of companies dominate the shipments. ALKEM LABORATORIES LIMITED holds the largest share at 33.0% (export value: $12.5M). Close behind, NATCO PHARMA LIMITED (32.8%, $12.4M). BIOCON PHARMA LIMITED (4.7%, $1.8M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Everolimus? Top Manufacturers & Their Buyers
Flow of Everolimus from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Everolimus Supplier Network — Key Market Intelligence
The Everolimus export market from India is led by ALKEM LABORATORIES LIMITED, which alone commands a 33.0% share, shipping $12.5M worth of product across 95 shipments. The second-largest exporter, NATCO PHARMA LIMITED, contributes $12.4M (32.8%) to the overall market. Combined, the top two suppliers alone account for 65.8% of all Everolimus exports, indicating a relatively concentrated supply base.
Across all 87 tracked manufacturers, the total Everolimus export value stands at $37.9M from 620 shipments. The market average shipment value is $61.1K. The single largest buyer relationship in terms of trade value is ASCEND GMBH, receiving $5.8M worth of product.
The combined buyer network spans 14 named purchasing companies, including ASCEND GMBH, ASCEND LABORATORIES LLC, BRECKENRIDGE PHARMACEUTICAL, PHARMACARE PREMIUM, BOSTON ONCOLOGY ARABIA and 9 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1ALKEM LABORATORIES LIMITED
ALKEM LABORATORIES LIMITED is the first-largest Everolimus exporter from India, with a market share of 33.0% and a total export value of $12.5M across 95 shipments. Their average shipment value of $131.7K is above the market average of $61.1K, suggesting premium or bulk contract pricing.
ALKEM LABORATORIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• ASCEND GMBH — $5.8M across 44 shipments (46.2% of this supplier's total exports)
• ASCEND LABORATORIES LLC — $4.3M across 32 shipments (34.1% of this supplier's total exports)
• ASCEND LABORATORIES LLC — $2.2M across 17 shipments (17.5% of this supplier's total exports)
• ASCEND LABORATORIES LLC — $155.6K across 1 shipments (1.2% of this supplier's total exports)
• ASCEND LABORATORIES LLC — $119.9K across 1 shipments (1.0% of this supplier's total exports)
Key Insight: ALKEM LABORATORIES LIMITED's per-shipment value of $131.7K is 116% above the market average of $61.1K, consistent with large-order contracts or value-added formulations.
2NATCO PHARMA LIMITED
NATCO PHARMA LIMITED is the second-largest Everolimus exporter from India, with a market share of 32.8% and a total export value of $12.4M across 223 shipments. Their average shipment value of $55.6K is below the market average of $61.1K, reflecting a high-volume, competitive pricing strategy.
NATCO PHARMA LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• BRECKENRIDGE PHARMACEUTICAL — $4.1M across 73 shipments (32.7% of this supplier's total exports)
• PHARMACARE PREMIUM — $3.2M across 57 shipments (25.7% of this supplier's total exports)
• BOSTON ONCOLOGY ARABIA — $2.6M across 46 shipments (20.7% of this supplier's total exports)
• BRECKENRIDGE PHARMACEUTICAL — $1.5M across 27 shipments (12.1% of this supplier's total exports)
• BRECKENRIDGE PHARMACEUTICAL — $1.1M across 20 shipments (8.8% of this supplier's total exports)
Key Insight: NATCO PHARMA LIMITED operates with high shipment frequency (223 shipments) at a per-shipment value of $55.6K, indicating a broad distribution network with many smaller, regular orders.
3BIOCON PHARMA LIMITED
BIOCON PHARMA LIMITED is the third-largest Everolimus exporter from India, with a market share of 4.7% and a total export value of $1.8M across 5 shipments. Their average shipment value of $354.7K is above the market average of $61.1K, suggesting premium or bulk contract pricing.
BIOCON PHARMA LIMITED serves 2 named buyers in our database. BIOCON PHARMA INC is the dominant customer, accounting for 63.2% of this supplier's tracked business. Top customers include:
• BIOCON PHARMA INC — $1.1M across 3 shipments (63.2% of this supplier's total exports)
• XXOCOXXPHAXXA IXX — $653.6K across 2 shipments (36.8% of this supplier's total exports)
Key Insight: BIOCON PHARMA LIMITED's per-shipment value of $354.7K is 481% above the market average of $61.1K, consistent with large-order contracts or value-added formulations.
4BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED
BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED is the fourth-largest Everolimus exporter from India, with a market share of 1.3% and a total export value of $491.9K across 15 shipments. Their average shipment value of $32.8K is below the market average of $61.1K, reflecting a high-volume, competitive pricing strategy.
BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED serves 5 named buyers in our database. SUNIME LIMITED is the dominant customer, accounting for 86.4% of this supplier's tracked business. Top customers include:
• SUNIME LIMITED — $424.8K across 13 shipments (86.4% of this supplier's total exports)
• PHARASS — $33.4K across 1 shipments (6.8% of this supplier's total exports)
• RIPHALT — $31.5K across 1 shipments (6.4% of this supplier's total exports)
• TANEPVLT — $1.6K across 0 shipments (0.3% of this supplier's total exports)
• ONCOLT — $524 across 0 shipments (0.1% of this supplier's total exports)
Key Insight: BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED operates with high shipment frequency (15 shipments) at a per-shipment value of $32.8K, indicating a broad distribution network with many smaller, regular orders.
5ALKEM LABORATORIES LTD
ALKEM LABORATORIES LTD is the fifth-largest Everolimus exporter from India, with a market share of 1.2% and a total export value of $464.8K across 17 shipments. Their average shipment value of $27.3K is below the market average of $61.1K, reflecting a high-volume, competitive pricing strategy.
ALKEM LABORATORIES LTD serves 2 named buyers in our database. ASCEND LABORATORIES LLC is the dominant customer, accounting for 61.6% of this supplier's tracked business. Top customers include:
• ASCEND LABORATORIES LLC — $286.2K across 10 shipments (61.6% of this supplier's total exports)
• ASCEND GMBH — $178.6K across 7 shipments (38.4% of this supplier's total exports)
Key Insight: ALKEM LABORATORIES LTD operates with high shipment frequency (17 shipments) at a per-shipment value of $27.3K, indicating a broad distribution network with many smaller, regular orders.
6AEON FORMULATIONS PRIVATE LIMITED
AEON FORMULATIONS PRIVATE LIMITED is the fifth-largest Everolimus exporter from India, with a market share of 0.1% and a total export value of $51.8K across 4 shipments. Their average shipment value of $13.0K is below the market average of $61.1K, reflecting a high-volume, competitive pricing strategy.
AEON FORMULATIONS PRIVATE LIMITED serves 2 named buyers in our database. LANKA THERAPEUTICS P is the dominant customer, accounting for 76.5% of this supplier's tracked business. Top customers include:
• LANKA THERAPEUTICS P — $39.6K across 3 shipments (76.5% of this supplier's total exports)
• LANKA THERAPEUTICS ( — $12.2K across 1 shipments (23.5% of this supplier's total exports)
Key Insight: AEON FORMULATIONS PRIVATE LIMITED operates with high shipment frequency (4 shipments) at a per-shipment value of $13.0K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Everolimus Flows
Once Everolimus leaves the manufacturing plants of companies like ALKEM LABORATORIES LIMITED and NATCO PHARMA LIMITED, it travels to 5 destination markets with a combined import value of $37.9M. United States absorbs the largest share at 50.5% ($19.1M), followed by Germany (15.7%) and Malta (10.4%).
In United States — the top destination — named importers include ASCEND LABORATORIES LLC, BRECKENRIDGE PHARMACEUTICAL INC, ASCEND LABORATORIES,LLC. In Germany, key buyers are ASCEND GMBH.
This geographic spread reflects Everolimus's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Everolimus Go? Top Importing Countries & Their Buyers
Trade flow of Everolimus exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1United States
United States ranks as the first-largest destination for Everolimus imports from India, with a total trade value of $19.1M across 211 shipments — representing a 50.5% share of all Everolimus exports. The average shipment value of $90.7K is above the global average of $61.1K, indicating high-value procurement contracts or branded formulations. This market is served by 10 tracked buyers.
Named Everolimus importers in United States: ASCEND LABORATORIES LLC is the largest buyer, accounting for 23.8% ($4.5M) of this market's total imports.
• ASCEND LABORATORIES LLC — $4.5M (23.8% of United States's total)
• BRECKENRIDGE PHARMACEUTICAL INC — $4.2M (21.7% of United States's total)
• ASCEND LABORATORIES,LLC — $2.6M (13.5% of United States's total)
Key Insight: United States's per-shipment average of $90.7K (48% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Everolimus imports from India.
2Germany
Germany ranks as the second-largest destination for Everolimus imports from India, with a total trade value of $6.0M across 27 shipments — representing a 15.7% share of all Everolimus exports. The average shipment value of $220.7K is above the global average of $61.1K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Everolimus importers in Germany: ASCEND GMBH is the largest buyer, accounting for 100.0% ($6.0M) of this market's total imports.
• ASCEND GMBH — $6.0M (100.0% of Germany's total)
Key Insight: Germany's per-shipment average of $220.7K (261% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Germany is a key market for Everolimus imports from India.
3Malta
Malta ranks as the third-largest destination for Everolimus imports from India, with a total trade value of $3.9M across 45 shipments — representing a 10.4% share of all Everolimus exports. The average shipment value of $87.4K is above the global average of $61.1K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Everolimus importers in Malta: PHARMACARE PREMIUM is the largest buyer, accounting for 100.0% ($3.9M) of this market's total imports.
• PHARMACARE PREMIUM — $3.9M (100.0% of Malta's total)
Key Insight: Malta's per-shipment average of $87.4K (43% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Malta is a key market for Everolimus imports from India.
4Brazil
Brazil ranks as the fourth-largest destination for Everolimus imports from India, with a total trade value of $3.1M across 17 shipments — representing a 8.3% share of all Everolimus exports. The average shipment value of $184.5K is above the global average of $61.1K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Everolimus importers in Brazil: NATCOFARMA DO BRASIL LTDA, is the largest buyer, accounting for 40.3% ($1.3M) of this market's total imports.
• NATCOFARMA DO BRASIL LTDA, — $1.3M (40.3% of Brazil's total)
• NATCOFARMA DO BRASIL LIMITEDA — $888.7K (28.3% of Brazil's total)
• NATCO FARMA DO BRASIL LTDA — $555.8K (17.7% of Brazil's total)
Key Insight: Brazil's per-shipment average of $184.5K (202% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Brazil is a key market for Everolimus imports from India.
5Saudi Arabia
Saudi Arabia ranks as the fifth-largest destination for Everolimus imports from India, with a total trade value of $2.6M across 6 shipments — representing a 6.8% share of all Everolimus exports. The average shipment value of $429.8K is above the global average of $61.1K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Everolimus importers in Saudi Arabia: BOSTON ONCOLOGY ARABIA is the largest buyer, accounting for 99.7% ($2.6M) of this market's total imports.
• BOSTON ONCOLOGY ARABIA — $2.6M (99.7% of Saudi Arabia's total)
Key Insight: Saudi Arabia's per-shipment average of $429.8K (604% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Saudi Arabia is a key market for Everolimus imports from India.
People Also Ask — Everolimus Supplier & Trade Network
Who are the top suppliers of Everolimus from India?+
Which companies buy Everolimus from Indian manufacturers?+
Where does Everolimus exported from India go?+
What is the market share of the top Everolimus supplier from India?+
What is the average shipment value for Everolimus exports from India?+
Is Everolimus manufactured in India and exported globally?+
Which country imports the most Everolimus from India?+
Who are the buyers of Everolimus in Germany?+
How concentrated is the Everolimus supplier market in India?+
How do I find verified buyers for Everolimus in specific countries?+
Everolimus Trade Network — Key Takeaways
- 1ALKEM LABORATORIES LIMITED is India's dominant Everolimus exporter with a 33.0% market share and $12.5M in total exports — making it the single most important sourcing entity in this market.
- 2The top 87 suppliers collectively account for 73.1% of all tracked Everolimus exports, with a combined trade value of $37.9M.
- 3United States is the largest destination market, absorbing 50.5% of India's Everolimus exports ($19.1M). Germany (15.7%) and Malta (10.4%) follow.
- 4With 620 total shipments averaging $61.1K each, the Everolimus export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include ASCEND GMBH, ASCEND LABORATORIES LLC, BRECKENRIDGE PHARMACEUTICAL, PHARMACARE PREMIUM — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 67 countries
Network value: $37.9M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Everolimus — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Everolimus.
- 2.Flow Mapping: 87 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 620 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 67 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
620 Verified Shipments
87 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists